Cited by 205Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsEndometriosis Research and Treatment

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

Open access
Guastella, Ettore, Longo, Rosa Alba, Carmina, Enrico·2010·Fertility and Sterility

Abstract

Objective To evaluate the clinical and endocrine differences between main polycystic ovary syndrome (PCOS) phenotypes.Design To evaluate clinical and hormone parameters in a large group of consecutive women with PCOS diagnosed according Rotterdam criteria and divided according their phenotype.Setting University department of medicine.Patient(s) Three hundred eighty-two consecutive women with PCOS and 85 ovulatory controls.Intervention(s) Evaluation of clinical and hormone parameters.Main outcome measure(s) Blood levels of gonadotropins, testosterone, sex-hormone-binding globulin, dehydroepiandrosterone sulfate, 17α-hydroxyprogesterone, progesterone, glucose, and insulin, and calculation of the free androgen index and insulin sensitivity.Result(s) The severe PCOS phenotype (hyperandrogenism, chronic anovulation, and polycystic ovaries: type I classic PCOS) was the most common phenotype in 53.9% of the patients. The phenotype of 8.9% of patients was characterized by hyperandrogenism and chronic anovulation but normal ovaries (type II classic PCOS). The two phenotypes of classic PCOS had similar clinical and endocrine characteristics, but the patients with polycystic ovaries had a higher luteinizing hormone/follicle-stimulating hormone (LH/FSH) ratio. Ovulatory PCOS was relatively common (28.8% of PCOS patients) and presented milder clinical and endocrine alterations than the classic PCOS phenotypes. The normoandrogenic phenotype was relatively uncommon. These patients had a normal body mass index, insulin sensitivity, and free androgen index but showed increased levels of LH and LH/FSH ratio.Conclusion(s) Ovulatory PCOS represents the mild form of classic PCOS, but the normoandrogenic phenotype, although part of the spectrum, may represent a different disorder or have a different pathogenetic pathway.

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2010.02.014

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Insulin resistance and hyperinsulinemia are intrinsic to polycystic ovary syndrome in adults and adolescents, whether lean or obese.

    “Insulin resistance and hyperinsulinemia are intrinsic to PCOS in adults and adolescents, lean or obese.”
  • With one published exception, current definitions of polycystic ovary syndrome in adolescent or adult women do not include insulin resistance or hyperinsulinemia as a diagnostic criterion.

    “With the exception of one published recommendation, none of the current definitions of PCOS in adolescent or adult women include insulin resistance/hyperinsulinemia as a diagnostic criterion [1, 10-12, 18, 19, 112]”
  • Hyperinsulinemia is believed to worsen hyperandrogenism and the reproductive and metabolic manifestations of polycystic ovary syndrome in adolescents.

    “Hyperinsulinemia is believed to exacerbate the hyperandrogenism and the reproductive and metabolic manifestations of PCOS in adolescents.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Guastella, E., Longo, R. A., & Carmina, E.
Affiliations
University of Palermo (IT)
Corresponding author
Carmina, Enrico
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2010-11
Volume
94
Issue
6
Pages
2197-2201
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2129451889
Cited by
205
References
23
Citations by year
2026: 10 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 15 · 2021: 22 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 11 · 2016: 16 · 2015: 15 · 2014: 9 · 2013: 16 · 2012: 19
FWCI
17.91
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
polycystic ovary syndrome, PCOS phenotypes, hyperandrogenism, chronic anovulation, LH/FSH ratio, insulin sensitivity, free androgen index, sex hormone-binding globulin, dehydroepiandrosterone sulfate, insulin resistance, Rotterdam criteria
MeSH terms
Adult, Androgens, Endocrine System, Female, Follicle Stimulating Hormone, Humans, Luteinizing Hormone, Phenotype, Polycystic Ovary Syndrome, Retrospective Studies, Sex Hormone-Binding Globulin, Prevalence, Case-Control Studies, Hyperandrogenism, Dehydroepiandrosterone Sulfate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review